Promoting cardiovascular health worldwide: Strategies, challenges, and opportunities;Promoción de la salud cardiovascular global: estrategias, retos y oportunidades

Revista Espanola de Cardiologia

Volumn 67, Issue 9, 2014, Pages 724-730

  Castellano, José M ^a,b   Narula, Jagat ^a   Castillo, Javier ^c   Fuster, Valentín ^a,b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular health promotion; Cardiovascular prevention; Cardiovascular risk factors; Global cardiovascular disease

Indexed keywords

BIOLOGICAL FACTOR;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMMUNITY; ECONOMIC DEVELOPMENT; GOVERNMENT; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INFECTION; LEADERSHIP; MORBIDITY; MORTALITY; ORGANIZATION AND MANAGEMENT; PANDEMIC; PREVALENCE; SOCIETY; CARDIOVASCULAR DISEASES; HEALTH; HEALTH PROMOTION; PROCEDURES; SECONDARY PREVENTION;

CARDIOVASCULAR DISEASES; GLOBAL HEALTH; HEALTH PROMOTION; HUMANS; SECONDARY PREVENTION;

EID: 84906938252     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.01.024     Document Type: Article

References (38)

1. World Health Statistics, 2012 2012 World Health Organization Ginebra
2. I.R. Dégano, R. Elosua, and J. Marrugat Epidemiología del síndrome coronario agudo en España: estimación del número de casos y la tendencia de 2005 a 2009 Rev Esp Cardiol 66 2013 472 481
3. K.G. Manton The global impact of noncommunicable diseases: estimates and projections World Health Stat Q 41 1987 255 266
4. S. Leeder, S. Raymond, H. Greenberg, H. Liu, and K. Esson A race against time: the challenge of cardiovascular disease in developing countries 2004 Trustees of Columbia University Nueva York
5. V. Fuster, J. Voute, M. Hunn, and S.C. Smith Jr. Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern Circulation 116 2007 1966 1970
6. V. Fuster, and B.B. Kelly editores. Promoting cardiovascular health in the developing world: a critical challenge to achieve global health 2010 The National Academies Press Washington
7. Global status report on noncommunicable diseases 2010 2011 World Health Organization Ginebra
8. o 310 [citado 17 Ene 2014]. Disponible en: http://who.int/mediacentre/factsheets/fs310/en/
9. R. Beaglehole, J. Epping-Jordan, V. Patel, M. Chopra, S. Ebrahim, and M. Kidd et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care Lancet 372 2008 940 949
10. R. Atun, S. Jaffar, S. Nishtar, F.M. Knaul, M.L. Barreto, and M. Nyirenda et al. Improving responsiveness of health systems to non-communicable diseases Lancet 381 2013 690 697
11. R. Beaglehole, R. Bonita, R. Horton, C. Adams, G. Alleyne, and P. Asaria et al. Priority actions for the non-communicable disease crisis Lancet 377 2011 1438 1447
12. H.R. Wurie, and F.P. Cappuccio Cardiovascular disease in low- and middle-income countries: an urgent priority Ethn Health 17 2012 543 550
13. B. Kelly, K.C. Ostapkovich, C. Weinberger, and V. Fuster Potential for global progress in control of chronic diseases: a turning point in 2011 Global Heart 6 2011 127 132
14. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, and V. Aboyans et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
15. L.J. Laslett, P. Alagona Jr., B.A. Clark 3rd, J.P. Drozda Jr., F. Saldivar, and S.R. Wilson et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology J Am Coll Cardiol 60 25 Suppl 2012 S1 S49
16. C.J. Murray, T. Vos, R. Lozano, M. Naghavi, A.D. Flaxman, and C. Michaud et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2197 2223
17. A.R. Hosseinpoor, N. Bergen, S. Mendis, S. Harper, E. Verdes, and A. Kunst et al. Socioeconomic inequality in the prevalence of noncommunicable diseases in low- and middle-income countries: results from the World Health Survey BMC Public Health 12 2012 474
18. A. Alwan, D.R. Maclean, L.M. Riley, E.T. D'Espaignet, C.D. Mathers, and G.A. Stevens et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries Lancet 376 2010 1861 1868
19. S. Yusuf, S. Hawken, S. Ounpuu, T. Dans, A. Avezum, and F. Lanas et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
20. R. Moodie, D. Stuckler, C. Monteiro, N. Sheron, B. Neal, and T. Thamarangsi et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries Lancet 381 2013 670 679
21. M.J. O'Donnell, D. Xavier, L. Liu, H. Zhang, S.L. Chin, and P. Rao-Melacini et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study Lancet 376 2010 112 123
22. D.M. Lloyd-Jones, E.P. Leip, M.G. Larson, R.B. D'Agostino, A. Beiser, and P.W. Wilson et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 2006 791 798
23. J. Marrugat, J. Vila, J.M. Baena-Díez, M. Grau, J. Sala, and R. Ramos et al. Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR Rev Esp Cardiol 64 2011 385 394
24. G. Rose Strategy of prevention: lessons from cardiovascular disease Br Med J (Clin Res Ed) 282 1981 1847 1851
25. M. Franco, R. Cooper, U. Bilal, and V. Fuster Control de los factores de riesgo coronarios y terapias basadas en la evidencia: esfuerzos coordinados para la prevención cardiovascular en España Rev Esp Cardiol 64 2011 962 964
26. D.R. Labarthe Prevention of cardiovascular risk factors in the first place Prev Med 29 1999 S72 S78
27. J.D. Sargent, E. Demidenko, D.J. Malenka, Z. Li, H. Gohlke, and R. Hanewinkel Smoking restrictions and hospitalization for acute coronary events in Germany Clin Res Cardiol 101 2012 227 235
28. S. Yusuf, S. Islam, C.K. Chow, S. Rangarajan, G. Dagenais, and R. Diaz et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey Lancet 378 2011 1231 1243
29. J.M. Castellano, R. Copeland-Halperin, and V. Fuster Aiming at strategies for a complex problem of medical nonadherence Global Heart 8 2013 263 271
30. E.S. Ford, U.A. Ajani, J.B. Croft, J.A. Critchley, D.R. Labarthe, and T.E. Kottke et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
31. K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyörä lä, U. Keil EUROASPIRE Study Group EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries Eur J Cardiovasc Prev Rehabil 16 2009 121 137
32. S. Mendis, D. Abegunde, S. Yusuf, S. Ebrahim, G. Shaper, and H. Ghannem et al. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE) Bull World Health Organ 83 2005 820 829
33. R. Joshi, C.K. Chow, P.K. Raju, R. Raju, K.S. Reddy, and S. Macmahon et al. Fatal and nonfatal cardiovascular disease and the use of therapies for secondary prevention in a rural region of India Circulation 119 2009 1950 1955
34. D. Butler UN targets top killers Nature 477 2011 260 261
35. G. Sanz, and V. Fuster Maximizing therapeutic envelope for prevention of cardiovascular disease: role of polypill Mt Sinai J Med 79 2012 683 688
36. A. Shroufi, R. Chowdhury, R. Anchala, S. Stevens, P. Blanco, and T. Han et al. Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review BMC Public Health 13 2013 285
37. P. Asaria, D. Chisholm, C. Mathers, M. Ezzati, and R. Beaglehole Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use Lancet 370 2007 2044 2053
38. G. Paradis, and A. Chiolero The cardiovascular and chronic diseases epidemic in low- and middle-income countries: a global health challenge J Am Coll Cardiol 57 2011 1775 1777